title: Absorption and disposition of MeIQx in man: lessons for human dosimetry.
authors.affiliation: Department of Clinical Pharmacology, Royal Postgraduate Medical School, London, United Kingdom.
authors.forename: A R
authors.initials: AR
authors.lastname: Boobis
authors.forename: N J
authors.initials: NJ
authors.lastname: Gooderham
authors.forename: B P
authors.initials: BP
authors.lastname: Murray
authors.forename: S
authors.initials: S
authors.lastname: Murray
authors.forename: A
authors.initials: A
authors.lastname: Lynch
authors.forename: D
authors.initials: D
authors.lastname: Sesardic
authors.forename: D S
authors.initials: DS
authors.lastname: Davies
mesh_terms: D000042:Absorption; D000818:Animals; D001711:Biotransformation; D002273:Carcinogens / Q000008:administration & dosage / Q000378:metabolism / Q000493:pharmacokinetics; D004305:Dose-Response Relationship, Drug; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D009153:Mutagens / Q000008:administration & dosage / Q000378:metabolism / Q000493:pharmacokinetics*; D011810:Quinoxalines / Q000008:administration & dosage / Q000378:metabolism / Q000493:pharmacokinetics*
chemical_list: D002273:Carcinogens; D006454:Hemoglobins; D009153:Mutagens; D011810:Quinoxalines; C036990:2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline